Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$887M |
| 2 |
Amazon
AMZN
|
+$857M |
| 3 |
Apple
AAPL
|
+$844M |
| 4 |
Microsoft
MSFT
|
+$802M |
| 5 |
Tesla
TSLA
|
+$606M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$760M |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$515M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$258M |
| 4 |
Oracle
ORCL
|
+$126M |
| 5 |
PFPT
Proofpoint, Inc.
PFPT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.53% |
| 2 | Financials | 13.97% |
| 3 | Healthcare | 13.42% |
| 4 | Consumer Discretionary | 11.85% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Arcutis Biotherapeutics
ARQT
$3.25B
| $11.7M | ﹤0.01% |
488,855
+13,888
| +3% | +$317K |
|
2352
PDF Solutions
PDFS
$2.13B
| $11.7M | ﹤0.01% |
506,460
-782
| -0.2% | -$16.1K |
|
2353
Helix Energy Solutions
HLX
$1.49B
| $11.7M | ﹤0.01% |
3,004,569
+366,054
| +14% | +$1.51M |
|
2354
Accel Entertainment
ACEL
$1.01B
| $11.6M | ﹤0.01% |
953,178
+39,153
| +4% | +$448K |
|
2355
uniQure
QURE
$3.26B
| $11.6M | ﹤0.01% |
360,993
-30,374
| -8% | -$926K |
|
2356
Hawkins
HWKN
$2.67B
| $11.6M | ﹤0.01% |
331,198
-2,850
| -0.9% | -$98.6K |
|
2357
Curis
CRIS
$3.91M
| $11.5M | ﹤0.01% |
3,682
+235
| +7% | +$734K |
|
2358
Community Trust Bancorp
CTBI
$1.44B
| $11.5M | ﹤0.01% |
273,616
-1,923
| -0.7% | -$77.9K |
|
2359
HCI Group
HCI
$2.32B
| $11.5M | ﹤0.01% |
103,974
+354
| +0.3% | +$36.9K |
|
2360
Veritone
VERI
$139M
| $11.5M | ﹤0.01% |
482,014
+20,494
| +4% | +$418K |
|
|
FRTA
2361
DELISTED
Forterra, Inc
FRTA
| $11.5M | ﹤0.01% |
488,300
+63,437
| +15% | +$1.49M |
|
2362
Universal Electronics
UEIC
$66.6M
| $11.5M | ﹤0.01% |
233,566
+717
| +0.3% | +$34.8K |
|
2363
Sanofi
SNY
$105B
| $11.5M | ﹤0.01% |
238,081
-45,697
| -16% | -$2.32M |
|
2364
Kelly Services Class A
KELYA
$566M
| $11.4M | ﹤0.01% |
605,723
-3,211
| -0.5% | -$67.3K |
|
|
FMTX
2365
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $11.4M | ﹤0.01% |
492,369
+45,722
| +10% | +$1.08M |
|
|
TA
2366
DELISTED
TravelCenters of America LLC
TA
| $11.4M | ﹤0.01% |
229,274
-1,966
| -0.9% | -$73.6K |
|
2367
Core Laboratories
CLB
$569M
| $11.4M | ﹤0.01% |
410,759
+27,908
| +7% | +$850K |
|
|
ACRE
2368
Ares Commercial Real Estate
ACRE
$264M
| $11.4M | ﹤0.01% |
754,888
+97,622
| +15% | +$1.48M |
|
2369
Core & Main
CNM
$8.64B
| $11.4M | ﹤0.01% |
+433,119
| New | +$11.5M |
|
2370
Logitech
LOGI
$15B
| $11.3M | ﹤0.01% |
128,646
+682
| +0.5% | +$73.7K |
|
2371
CarParts.com
PRTS
$50.3M
| $11.3M | ﹤0.01% |
72,650
+3,535
| +5% | +$614K |
|
|
NBP
2372
NovaBridge Biosciences American Depositary Shares
NBP
$220M
| $11.3M | ﹤0.01% |
157,100
+18,009
| +13% | +$1.3M |
|
|
EBIX
2373
DELISTED
Ebix Inc
EBIX
| $11.3M | ﹤0.01% |
419,511
-21,665
| -5% | -$635K |
|
2374
Rigel Pharmaceuticals
RIGL
$762M
| $11.3M | ﹤0.01% |
310,554
+12,641
| +4% | +$498K |
|
2375
Global Industrial
GIC
$1.49B
| $11.3M | ﹤0.01% |
297,433
+3,704
| +1% | +$139K |
|
Similar funds
Geode Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
- Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
- Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
- Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
- Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
- Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
- Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.
Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.